ATC Group: A08AX Other antiobesity drugs

The World Health Organization's ATC classification organizes medical drugs based on therapeutic properties, chemical composition, and anatomy. It helps make essential medicines readily available globally and is widely used in the pharmaceutical industry.

Position of A08AX in the ATC hierarchy

Level Code Title
1 A Alimentary tract and metabolism
2 A08 Antiobesity preparations, excl. diet products
3 A08A Antiobesity preparations, excl. diet products
4 A08AX Other antiobesity drugs

Group A08AX contents

Code Title
A08AX01 Rimonabant

Active ingredients in A08AX

Active Ingredient Description

Rimonabant is a selective cannabinoid-1 receptor (CB1) antagonist that inhibits the pharmacological effects of cannabinoid agonists in vitro and in vivo. The endocannabinoid system is a physiological system present in brain and peripheral tissues (including adipocytes) that affects energy balance, glucose and lipid metabolism and body weight, and in neurons of the mesolimbic system modulates the intake of highly palatable, sweet or fatty foods.

Related product monographs

Title Information Source Document Type  
ACOMPLIA Film-coated tablet European Medicines Agency (EU) MPI, EU: SmPC